Amy Goodman
@DemocracyNow·3.2M subscribers·19.4K videos
Why Did the FDA Go Easy on Generic Drug Makers After Inspections Exposed Quality & Safety Concerns?
Posted
May 20, 2019
Views
9,188
Likes
391
Comments
60
Engagement
May 20, 2019
9,188
391
60
4.91%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
14:51Now PlayingPart 2 of our interview with investigative journalist Katherine Eban, who says generic drug manufacturers are cutting corners at the cost of safety and getting away with it. Her new book is Bottle of Lies: The Inside Story of the Generic Drug Boom. Generic drugs amount to 90% of all prescriptions filled in the U.S., most of them made in plants in India and China.
Watch Part 1
#DemocracyNow
Democracy Now! is an independent global news hour that airs on nearly 1,400 TV and radio stations Monday through Friday. Watch our livestream 89AM ET
Please consider supporting independent media by making a donation to Democracy Now! today
FOLLOW DEMOCRACY NOW! ONLINE:
Daily Email Digest
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
